Contract 75F40120C00199
The Critical Path Institute · Department Of Health And Human Services · September 29, 2020
The Critical Path Institute was awarded a federal contract by Department Of Health And Human Services (Food And Drug Administration) on September 29, 2020 for $387,000 of work in research and development in biotechnology (except nanobiotechnology). Performance is in Tucson, AZ. It was awarded under full and open competition. It uses firm fixed-price contract pricing. If all options are exercised, the contract could reach $1.13 million.
Contract details
- PIID
- 75F40120C00199
- Award type
- Definitive Contract
- Pricing
- Firm Fixed Price
- Set-aside
- No Set Aside Used.
- Competition
- Full And Open Competition
- NAICS
- 541714 · Research And Development In Biotechnology (Except Nanobiotechnology)
- Product / service
- R&D- Medical: Biomedical (Basic Research)
- Place of performance
- Tucson, AZ
- First action
- September 29, 2020
Description
PMWP 108 MODEL-INFORMED DRUG DEVELOPMENT (MIDD) IN THE EVALUATION AND DEVELOPMENT OF NEUROLOGICAL DRUG PRODUCTS
Modification timeline
-
September 29, 2020Base award$1.13M
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Vericel Corporation | Department Of Health And Human Services | April 1, 2026 | $34.88M |
| American College Of Medical Toxicology, Inc. | Department Of Health And Human Services | March 31, 2026 | $0 |
| Ceramedix Holding, Llc | Department Of Health And Human Services | March 31, 2026 | $4.22M |
| Glaxosmithkline, Llc | Department Of Health And Human Services | March 31, 2026 | $7.79M |
| Care Access Research Llc | Department Of Health And Human Services | March 31, 2026 | $2.55M |
| Pattern Bioscience, Inc. | Department Of Health And Human Services | March 31, 2026 | $22.50M |
Top contractors in NAICS 541714
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Amgen USA Inc | 1 | $59.99M |
| 2 | Vericel Corporation | 1 | $34.88M |
| 3 | Spectral Md, Inc. | 1 | $31.67M |
| 4 | Ppd Development Lp | 6 | $31.12M |
| 5 | L3 Technologies, Inc. | 1 | $22.00M |
| 6 | Technical Resources International, Inc. | 6 | $21.80M |
| 7 | Abbott Laboratories | 1 | $21.01M |
| 8 | Paratek Pharmaceuticals, Inc | 1 | $17.47M |
| 9 | Ossium Health, Inc. | 1 | $12.39M |
| 10 | Rho Federal Systems Division Inc | 1 | $8.00M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 75F40120C00199?
Contract 75F40120C00199 is a federal contract awarded to The Critical Path Institute by Department Of Health And Human Services on September 29, 2020 for $387,000 of work classified under RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY). It has been modified 0 times since the base award.
Who won contract 75F40120C00199?
The Critical Path Institute won contract 75F40120C00199 from Department Of Health And Human Services.
How much is contract 75F40120C00199 worth?
Contract 75F40120C00199 has obligated $387,000 to date, with a total potential value of $1.13 million if all options are exercised.